period of exclusivity
(2) The term “period of exclusivity”, with respect to a drug approved under section 355(c) of this title , means any period of exclusivity under clause (ii), (iii), or (iv) of section 355(c)(3)(E) of this title , clause (ii), (iii), or (iv) of section 355(j)(5)(F) of this title , or section 355a, 355f, or 360cc of this title.